Factors associated with human papillomavirus vaccination among young adult women in the United States

Vaccine

Volumn 31, Issue 28, 2013, Pages 2937-2946

  Williams, Walter W ^a   Lu, Peng Jun ^a   Saraiya, Mona ^b   Yankey, David ^a   Dorell, Christina ^a   Rodriguez, Juan L ^b   Kepka, Deanna ^c   Markowitz, Lauri E ^d  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Adult vaccination; Cervical cancer; HPV vaccine; Human papillomavirus; Pap smear; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BIVARIATE ANALYSIS; CANCER SCREENING; DRUG SAFETY; FEMALE; GYNECOLOGIST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSTETRICIAN; PATIENT ATTITUDE; PHYSICIAN; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION;

EID: 84884700558     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.041     Document Type: Article

References (42)

1. Centers for Disease Control and Prevention (CDC) Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007, 56(RR-2):1-24.
2. Centers for Disease Control and Prevention (CDC). FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010, 59(20):626-629.
3. Feldman S. Making sense of the new cervical-cancer screening guidelines. N Engl J Med 2011, 365:2145-2147.
4. Vesco K.K., Whitlock E.P., Eder M., et al. Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force. Ann Intern Med 2011, 155:698-705.
5. Saslow D., Solomon D., Lawson H.W., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012, 137:516-542.
6. Moyer (on behalf of the U.S.Preventive Services Task Force) V.A. Screening of cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012, 156:880-891.
7. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med 2009, 48:426-431.
8. Caskey R., Lindau S.T., Alexander G.C. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009, 45:453-462.
9. Taylor L.D., Hariri S., Sternberg M., Dunne E.F., Markowitz L.E. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med 2011, 52:398-400.
10. Anhang Price R., Tiro J.A., Saraiya M., Meissner H., Breen N. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer 2011, 17:5560-5568.
11. Dempsey A., Cohn L., Dalton V., Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011, 29:528-534.
12. Bednarczyk R.A., Birkhead G.S., Morse D.L., Doleyres H., McNutt L.A. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine 2011, 29:3138-3143.
13. Shah B, Barnwell B, Bieier G. SUDAAN User's Manual, Release 10.1. Research Triangle Park, NC: Research Triangle Institute; 2010.
14. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010, 171:357-367.
15. Allen J.D., Mohllajee A.P., Shelton R.C., et al. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2009, 48:420-425.
16. Dempsey A., Cohn L., Dalton V.A., Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010, 28:989-995.
17. Sudano J.J., Baker D.W. Intermittent lack of health insurance coverage and use of preventive services. Am J Public Health 2003, 93:130-137.
18. Beal AC, Doty MM, Hernandez SE, et al. Closing the divide: how medical homes promote equity in health care - results from the Commonwealth Fund 2006 Health Care Quality Survey. The Commonwealth Fund, New York, NY.; [accessed 05.04.12]. http://www.commonwealthfund.org/Publications/Fund-Reports/2007/Jun/Closing-the-Divide-How-Medical-Homes-Promote-Equity-in-Health-Care-Results-From-The-Commonwealth-F.aspx.
19. 111th Congress. Public Law 111-148-March. 23, 2010. 124 STAT. 119 (H.R. 3590). An Act Entitled: The Patient Protection and Affordable Care Act.; [accessed 24.05.11]. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf.
20. Rosenthal S.L., Weiss T.W., Zimet G.D., et al. Predictors of HPV vaccine uptake among women age 19-26: importance of a physician's recommendation. Vaccine 2011, 29:890-895.
21. Singleton J.A., Santibanez T.A., Wortley P.M. Influenza and pneumococcal vaccination of adults age ≥65: racial/ethnic differences. Am J Prev Med 2005, 29:412-420.
22. Walker F.J., Singleton J.A., Lu P-J., et al. Influenza vaccination of health care workers in the United States, 1989-2002. Infect Control Hosp Epidemiol 2006, 27:257-265.
23. Lindley M.C., Wortley P.M., Winston C.A., Bardenheier B.H. The role of attitudes in understanding disparities in adult influenza vaccination. Am J Prev Med 2006, 31:281-285.
24. Singleton J.A., Greby S.M., Wooten K.G., et al. Influenza, pneumococcal, and tetanus toxoid vaccination of adults-United States, 1993-1997. MMWR 2000, 49:39-50.
25. Link M.W., Ahluwalia I.B., Euler G.L., et al. Racial and ethnic disparities in influenza vaccination coverage among adults during the 2004-2005 season. Am J Epidemiol 2006, 163:571-578.
26. Bach P.B., Pham H.H., Schrag D., Tate R.C., Hargraves J.L. Primary care physicians who treat blacks and whites. N Engl J Med 2004, 351:575-584.
27. Schneider E.C., Zaslavsky A.M., Epstein A.M. Racial disparities in the quality of care for enrollees in medicare manage care. JAMA 2002, 287:1288-1294.
28. Gemson D.H., Elinson J., Messeri P. Differences in physician prevention practice patterns for white and minority patients. Community Health (Bristol) 1988, 13:53-64.
29. C.D.C. Reasons reported by medicare beneficiaries for not receiving influenza and pneumococcal vaccinations-United States, 1996. MMWR 1999, 48:886-890.
30. Agency for Healthcare Research and Quality. National healthcare disparities report. Rockville, MD: Agency for Healthcare Research and Quality; 2011. Publication no. 11-0005. Available at; [accessed 30.03.12]. http://www.ahrq.gov/qual/qrdr10.htm.
31. Wei F., Moore P.C., Green A.L. Geographic variability in human papillomavirus vaccination among U.S. young women. Am J Prev Med 2013, 44:154-157.
32. CDC. National and state vaccination coverage among adolescents aged 13-17 years - United States, 2011. MMWR 2012; 61:671-7.
33. Hughes C.C., Jones A.L., Feemster K.A., Fiks A.G. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatrics 2011, 11:74-82.
34. Merck Vaccine Patient Assistance Program. Available at:; [accessed 06.02.12]. http://www.merck.com/merckhelps/vaccines/qualify.html.
35. Briss P.A., Rodewald L.E., Hinman A.R., Shefer A.M., Strikas R.A., Bernier R.R., et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med 2000, 18(Suppl.):97-140.
36. Task Force on Community Prevention Services. The guide to community preventive services. New York, NY: Oxford University Press. Available at; 2005 [accessed 30.03.12]. http://www.thecommunityguide.org/library/book/index.html.
37. Donald R.M., Baken L., Nelson A., Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999, 16:173-177.
38. Mangtani P., Shah A., Roberts J.A. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect 2007, 135:139-143.
39. Zimmerman R.K., Raymund M., Janosky J.E., et al. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003, 21:1486-1491.
40. Shenson D., DiMartino D., Bolen J., Campbell M., Lu P.J., Singleton J.A. Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program. Vaccine 2005, 23:1015-1020.
41. Stupiansky N.W., Zimet G.D., Cummings T., Fortenberry J.D., Shew M. Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. J Adolesc Health 2012, 50:103-105.
42. Poland G.A., Shefer A.M., McCauley M., Webster P.S., Whitely-Williams P.N., Peter G., et al. Standards for adult immunization practice. Am J Prev Med 2003, 25(2):144-150.